GABAA receptor agonist muscimol can reset the phase of neural activity rhythm in the rat suprachiasmatic nucleus in vitro

Keiko Tominaga, Shigenobu Shibata, Toshiyuki Hamada, Shigenori Watanabe

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

We investigated the phase-resetting effect of muscimol, γ-amino butyric acid (GABA)A receptor agonist, on the circadian neural activity rhythm of the rat suprachiasmatic nucleus (SCN), which contains a circadian pacemaker. Acute application of muscimol inhibited the neural activity of the SCN in a dose-dependent manner. Under the tissue culture condition, the treatment with 10 μM muscimol during the early- to mid-subjective day on the first day (day 1) in vitro produced the largest phase advance in neural activity rhythm of the SCN on day 2. By contrast, the administration of muscimol during the subjective night produced no change. These phase changes were similar to those reported for dark pulses in constant light. These findings indicate that muscimol can directly affect SCN neurons and reset the circadian pacemaker in the SCN. The GABA neural function through the activation of GABAA receptors may play a role in modulating the phase of the SCN clock, especially during the subjective day.

Original languageEnglish
Pages (from-to)81-84
Number of pages4
JournalNeuroscience Letters
Volume166
Issue number1
DOIs
Publication statusPublished - 1994 Jan 17
Externally publishedYes

Fingerprint

GABA-A Receptor Agonists
Muscimol
Suprachiasmatic Nucleus
Butyric Acid
GABA-A Receptors
gamma-Aminobutyric Acid
In Vitro Techniques
Neurons
Light

Keywords

  • Circadian rhythm
  • GABA
  • GABA
  • In vitro
  • Muscimol
  • Suprachiasmatic nucleus

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

GABAA receptor agonist muscimol can reset the phase of neural activity rhythm in the rat suprachiasmatic nucleus in vitro. / Tominaga, Keiko; Shibata, Shigenobu; Hamada, Toshiyuki; Watanabe, Shigenori.

In: Neuroscience Letters, Vol. 166, No. 1, 17.01.1994, p. 81-84.

Research output: Contribution to journalArticle

@article{c1731814d8c04dea9610365bc764dc0b,
title = "GABAA receptor agonist muscimol can reset the phase of neural activity rhythm in the rat suprachiasmatic nucleus in vitro",
abstract = "We investigated the phase-resetting effect of muscimol, γ-amino butyric acid (GABA)A receptor agonist, on the circadian neural activity rhythm of the rat suprachiasmatic nucleus (SCN), which contains a circadian pacemaker. Acute application of muscimol inhibited the neural activity of the SCN in a dose-dependent manner. Under the tissue culture condition, the treatment with 10 μM muscimol during the early- to mid-subjective day on the first day (day 1) in vitro produced the largest phase advance in neural activity rhythm of the SCN on day 2. By contrast, the administration of muscimol during the subjective night produced no change. These phase changes were similar to those reported for dark pulses in constant light. These findings indicate that muscimol can directly affect SCN neurons and reset the circadian pacemaker in the SCN. The GABA neural function through the activation of GABAA receptors may play a role in modulating the phase of the SCN clock, especially during the subjective day.",
keywords = "Circadian rhythm, GABA, GABA, In vitro, Muscimol, Suprachiasmatic nucleus",
author = "Keiko Tominaga and Shigenobu Shibata and Toshiyuki Hamada and Shigenori Watanabe",
year = "1994",
month = "1",
day = "17",
doi = "10.1016/0304-3940(94)90845-1",
language = "English",
volume = "166",
pages = "81--84",
journal = "Neuroscience Letters",
issn = "0304-3940",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - GABAA receptor agonist muscimol can reset the phase of neural activity rhythm in the rat suprachiasmatic nucleus in vitro

AU - Tominaga, Keiko

AU - Shibata, Shigenobu

AU - Hamada, Toshiyuki

AU - Watanabe, Shigenori

PY - 1994/1/17

Y1 - 1994/1/17

N2 - We investigated the phase-resetting effect of muscimol, γ-amino butyric acid (GABA)A receptor agonist, on the circadian neural activity rhythm of the rat suprachiasmatic nucleus (SCN), which contains a circadian pacemaker. Acute application of muscimol inhibited the neural activity of the SCN in a dose-dependent manner. Under the tissue culture condition, the treatment with 10 μM muscimol during the early- to mid-subjective day on the first day (day 1) in vitro produced the largest phase advance in neural activity rhythm of the SCN on day 2. By contrast, the administration of muscimol during the subjective night produced no change. These phase changes were similar to those reported for dark pulses in constant light. These findings indicate that muscimol can directly affect SCN neurons and reset the circadian pacemaker in the SCN. The GABA neural function through the activation of GABAA receptors may play a role in modulating the phase of the SCN clock, especially during the subjective day.

AB - We investigated the phase-resetting effect of muscimol, γ-amino butyric acid (GABA)A receptor agonist, on the circadian neural activity rhythm of the rat suprachiasmatic nucleus (SCN), which contains a circadian pacemaker. Acute application of muscimol inhibited the neural activity of the SCN in a dose-dependent manner. Under the tissue culture condition, the treatment with 10 μM muscimol during the early- to mid-subjective day on the first day (day 1) in vitro produced the largest phase advance in neural activity rhythm of the SCN on day 2. By contrast, the administration of muscimol during the subjective night produced no change. These phase changes were similar to those reported for dark pulses in constant light. These findings indicate that muscimol can directly affect SCN neurons and reset the circadian pacemaker in the SCN. The GABA neural function through the activation of GABAA receptors may play a role in modulating the phase of the SCN clock, especially during the subjective day.

KW - Circadian rhythm

KW - GABA

KW - GABA

KW - In vitro

KW - Muscimol

KW - Suprachiasmatic nucleus

UR - http://www.scopus.com/inward/record.url?scp=0028177993&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028177993&partnerID=8YFLogxK

U2 - 10.1016/0304-3940(94)90845-1

DO - 10.1016/0304-3940(94)90845-1

M3 - Article

C2 - 8190363

AN - SCOPUS:0028177993

VL - 166

SP - 81

EP - 84

JO - Neuroscience Letters

JF - Neuroscience Letters

SN - 0304-3940

IS - 1

ER -